Skip to main content
. 2020 Nov 30;2020:5706561. doi: 10.1155/2020/5706561

Table 2.

Adjuvant chemotherapy regimens used in our study.

Regimen Percentage
FEC100 +Paclitaxel, n (%) 48 (72%)
FEC100 +Docetaxel, n (%) 5 (8%)
FEC100, n (%) 10 (15%)
EC n (%) 3 (5%)